Author/Authors :
Sacks، نويسنده , , Frank M. and Rouleau، نويسنده , , Jean-Lucien and Moye، نويسنده , , Lemuel A. and Pfeffer، نويسنده , , Marc A. and Warnica، نويسنده , , J. Wayne and Arnold، نويسنده , , J. Malcolm O. and Nash، نويسنده , , David T. and Brown، نويسنده , , Lisa E. and Sestier، نويسنده , , Francois and Rutherford، نويسنده , , John and Davis، نويسنده , , Barry R. and Hawkins، نويسنده , , C. Morton a، نويسنده ,
Abstract :
CARE will determine whether 5 years of cholesterol-lowering therapy reduces recurrent coronary disease events in 4,159 patients who have had an AMI. The mean total cholesterol and LDL-C levels in CARE (209 and 139 mg/dl) are similar to the average levels for the US population. The results of CARE will have relevance to the treatment of the majority of patients with coronary disease who have average rather than elevated cholesterol levels.
